Search results
Showing 1321 to 1335 of 1373 results for patients and public
NICE announces details of health technology evaluation methods review
Following approval at its recent Board meeting NICE has confirmed the details of its review of the methods it uses to develop guidance on drugs, medical devices and diagnostics.
NICE consults on changes to Interventional Procedures guidance programme
Proposals now out for consultation seek to formalise the involvement of medical device manufacturers
Today (Thursday 29 November), NICE opens a public consultation on its preliminary recommendations on the NHS use of the drug, pirfenidone (known commercially as Esbriet). The draft guidance assesses whether it should be recommended for use in people who have the lung condition, idiopathic pulmonary fibrosis.
NICE does not recommend elusulfase alfa for NHS use following evaluation of new evidence
NICE has today (12 November 2021) published draft guidance for public consultation which does not recommend elosulfase alfa (also called Vimizin and made by BioMarin) for the treatment of mucopolysaccharidosis type 4A (also known as MPS 4A and Morquio A syndrome).
Nasal spray medicine for treatment-resistant depression not recommended by NICE
Consultation open on draft guidance until Friday 25 September 2020
Dr Roberts, who is a qualified doctor, has 20 years’ experience in clinical and management posts in healthcare both in the private and public sector.
Dr Sam Roberts welcomes Dr Michael Borowitz as new NICE non-executive director
New NICE non-executive director appointment approved by the Secretary of State for Health and Social Care
Leading experts have dismissed claims that the formula used by NICE to recommend which drugs are funded on the NHS is 'flawed' and say that it is still the best available method for assessing drugs.
Would you like to find high quality evidenced-based information more quickly and easily? Are you looking for a one-stop resource that collates information from all the best sources ? such as Royal Colleges and the BNF?
Children with a rare, fatal, genetic disorder will be able to benefit from a new one-off treatment under new NICE guidance.
Broader types of data to be used in development of NICE guidance
An expanded evidence base could allow NICE to address evidence gaps and enhance reviews of the impact of our guidance
Children and young people need accurate, accessible information about their healthcare
New draft guidance from NICE published today recommends ensuring children and young people are fully informed about their health so that they are empowered to take an active role in their healthcare.
Cetuximab is not value for money says NICE in new draft guidance
Hundreds of people with cervical cancer are set to receive the first immunotherapy drug for an advanced form of the disease as NICE publishes final draft guidance today (Wednesday 29 March 2023) recommending its use in the Cancer Drugs Fund (CDF).
Antibiotics should not be issued as first line of treatment for a cough, says NICE and PHE
People should take honey or cough medicines instead but speak to their GP if it persists for longer than three weeks